Last reviewed · How we verify
HydroEye®
HydroEye® is an oral nutritional supplement containing omega-3 fatty acids and other nutrients designed to support tear film stability and reduce dry eye symptoms.
HydroEye® is an oral nutritional supplement containing omega-3 fatty acids and other nutrients designed to support tear film stability and reduce dry eye symptoms. Used for Dry eye disease / Keratoconjunctivitis sicca.
At a glance
| Generic name | HydroEye® |
|---|---|
| Sponsor | University of Alabama at Birmingham |
| Drug class | Nutritional supplement / Nutraceutical |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | FDA-approved |
Mechanism of action
The supplement provides essential fatty acids and micronutrients that support meibomian gland function and tear production. By improving the lipid layer of the tear film, it helps reduce evaporation and provides symptomatic relief in dry eye disease. The formulation is intended to address the nutritional deficiencies that may contribute to aqueous tear deficiency and meibomian gland dysfunction.
Approved indications
- Dry eye disease / Keratoconjunctivitis sicca
Common side effects
- Gastrointestinal upset
- Fishy aftertaste
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |